Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD

Overview of attention for article published in Respiratory Research, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 16 X posts from 16 X users, with an upper bound of 32,102 followers.

RT @RespiratoryBMC: New article: Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in #COPD https://t.co/aRpA0rV…

RT @RespiratoryBMC: New article: Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in #COPD https://t.co/aRpA0rV…

RT @RespiratoryBMC: New article: Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in #COPD https://t.co/aRpA0rV…

New article: Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in #COPD https://t.co/aRpA0rVvLi

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 12 additional X posts.